4.5 Article

Neutrophil-Lymphocyte Ratio as a Predictor of Cerebral Small Vessel Disease in a Geriatric Community: The I-Lan Longitudinal Aging Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio A Secondary Analysis of the RESCUE Clinical Trial

Nicholas H. Adamstein et al.

Summary: This post hoc analysis found that ziltivekimab can reduce the neutrophil-lymphocyte ratio (NLR), suggesting its potential in disrupting multiple atherogenic inflammatory pathways. Monitoring the NLR may be helpful in assessing the efficacy of ziltivekimab if it is introduced into clinical practice.

JAMA CARDIOLOGY (2023)

Article Immunology

Association of inflammatory markers with cerebral small vessel disease in community-based population

Lingling Jiang et al.

Summary: This community-based study found an association between neutrophil count (NC) and cerebral small vessel disease (CSVD), especially for basal ganglia perivascular spaces and lacunes, and provided evidence supporting the prognostic significance of NC.

JOURNAL OF NEUROINFLAMMATION (2022)

Article Medicine, General & Internal

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial

Camilla Huse et al.

Summary: This study found that tocilizumab can improve myocardial salvage in ST-elevation myocardial infarction (STEMI) patients by reducing neutrophil count and attenuating neutrophil function. In addition, the study also found that a lower CD8(+) count is associated with improved myocardial salvage in patients admitted to the hospital after a longer duration of symptoms.

EBIOMEDICINE (2022)

Article Clinical Neurology

Correlation between neutrophil/lymphocyte ratio and cognitive impairment in cerebral small vessel disease patients: A retrospective study

Lan Hou et al.

Summary: The blood neutrophil/lymphocyte ratio (NLR) is associated with an increased risk of mild cognitive impairment (CI) in patients with cerebral small vessel disease (CSVD). This study found that higher NLR in CSVD patients might be associated with an increased risk of CI.

FRONTIERS IN NEUROLOGY (2022)

Article Neurosciences

Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms

Liming Cao et al.

Summary: This study found a significant correlation between hyperhomocysteinemia and cerebral small vessel disease (CSVD), indicating it as a risk factor for lacunar infarction and severe white matter lesions. Further research is needed to understand its association with inflammatory mechanisms.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2021)

Article Clinical Neurology

Associations of Blood Pressure and Carotid Flow Velocity with Brain Volume and Cerebral Small Vessel Disease in a Community-Based Population

Shao-Yuan Chuang et al.

Summary: The study found associations between high blood pressure, low carotid flow velocity, brain volume, and CSVD. Adjusted analyses suggested that these factors may be involved in the pathophysiology of cognitive decline.

TRANSLATIONAL STROKE RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials

Nicholas H. Adamstein et al.

Summary: The study demonstrates that the neutrophil-lymphocyte ratio (NLR) can predict cardiovascular events and mortality risk, and can be reduced by anti-inflammatory therapy with canakinumab.

EUROPEAN HEART JOURNAL (2021)

Article Multidisciplinary Sciences

Neutrophil-to-lymphocyte ratio and mortality in the United States general population

Minkyo Song et al.

Summary: The study found that in the general population, NLR is associated with overall mortality and mortality due to specific causes such as heart disease, chronic lower respiratory disease, influenza/pneumonia, and kidney disease. Additionally, NLR is only associated with cancer mortality in the first follow-up year. These associations suggest potential effects of disordered inflammation and immunity on disease progression and etiology.

SCIENTIFIC REPORTS (2021)

Review Cardiac & Cardiovascular Systems

Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease

Paul M. Ridker et al.

Summary: IL-6 is a pivotal cytokine in innate immunity with a proatherogenic role in cardiovascular disease. Research has explored mechanisms of IL-6 signaling, murine models, and human epidemiological data regarding its utility as a biomarker of vascular risk.

CIRCULATION RESEARCH (2021)

Review Cell Biology

Dynamic roles of neutrophils in post-stroke neuroinflammation

Brooke J. Wanrooy et al.

Summary: Research on neutrophils in the neuroinflammatory cascade after ischemic stroke indicates their diverse roles in the acute stages, potentially eliciting both pro-inflammatory and anti-inflammatory effects. The uncertainty regarding the benefits or harms of neutrophil diversity in stroke remains, but if their hypothesized wound-healing functions can be validated, it may provide a promising therapeutic target for the majority of stroke patients currently without treatment.

IMMUNOLOGY AND CELL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Role of Purinergic Signalling in Endothelial Dysfunction and Thrombo-Inflammation in Ischaemic Stroke and Cerebral Small Vessel Disease

Natasha Ting Lee et al.

Summary: Cerebral endothelium plays a crucial role in regulating various physiological functions to maintain the health of the central nervous system. Cardiovascular risk factors contribute to cerebral endothelial dysfunction, leading to impaired vasodilation, aggravated inflammatory responses, increased oxidative stress, and vascular proliferation.

BIOMOLECULES (2021)

Review Clinical Neurology

Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis

J. J. McCabe et al.

Summary: This study conducted a systematic review and meta-analysis on the association between blood inflammatory markers and the risk of recurrent stroke or major vascular events (MVEs) after stroke. The findings indicated that CRP and fibrinogen were associated with recurrent stroke and MVEs, while IL-6 showed some trends but not statistically significant associations. Substantial methodological heterogeneity among studies was identified, highlighting the need for individual-patient pooled analysis and standardization of methods to determine the prognostic role of blood inflammatory markers.

EUROPEAN STROKE JOURNAL (2021)

Article Geriatrics & Gerontology

Elevated blood neutrophil to lymphocyte ratio in older adults with cognitive impairment

Jing-Hong Liu et al.

ARCHIVES OF GERONTOLOGY AND GERIATRICS (2020)

Review Cell Biology

Age-related cerebral small vessel disease and inflammaging

Tiemei Li et al.

CELL DEATH & DISEASE (2020)

Review Cell Biology

Inflammation and cerebral small vessel disease: A systematic review

Audrey Low et al.

AGEING RESEARCH REVIEWS (2019)

Article Immunology

The contribution of neutrophils to CNS autoimmunity

Emily R. Pierson et al.

CLINICAL IMMUNOLOGY (2018)

Article Immunology

The effect of systemic inflammation on human brain barrier function

Elliot Elwood et al.

BRAIN BEHAVIOR AND IMMUNITY (2017)

Review Hematology

The Relation Between Atherosclerosis and the Neutrophil-Lymphocyte Ratio

Sevket Balta et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2016)

Review Immunology

Neutrophils and stroke - Can neutrophils mitigate disease in the central nervous system?

Alexander S. Easton

INTERNATIONAL IMMUNOPHARMACOLOGY (2013)

Article Developmental Biology

Emerging roles of immune cells in luteal angiogenesis

Koumei Shirasuna et al.

REPRODUCTION FERTILITY AND DEVELOPMENT (2013)

Review Multidisciplinary Sciences

Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure

Filip K. Swirski et al.

SCIENCE (2013)

Article Neurosciences

A fast diffeomorphic image registration algorithm

John Ashburner

NEUROIMAGE (2007)

Article Rheumatology

Oxidant stress, inflammation and atherogenesis

G Davi et al.